Site Members can sign up for company wide alerts
Investigation Overview
October 06, 2014 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Ambit Biosciences Corp (NASDAQ:AMBI), was announced concerning whether the takeover of Ambit Biosciences Corp. by Daiichi Sankyo Company for $15 per share is unfair to NASDAQ:AMBI stockholders. The investigation by a law firm concerns whether certain officers and director...
You must register (for free) or login to view the entire investigation.